Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfe5d59fd6b14c02afc38a0af2583c78 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
filingDate |
2014-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d486683f772e0fcf466be328ffd235d |
publicationDate |
2014-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2014197008-A |
titleOfInvention |
Diagnostic and therapeutic methods and useful drugs |
abstract |
A method of screening for the amount of neoplastic cell death in a subject is provided. The method includes screening the expression level of telomerase protein and / or gene by dead cells in a subject or a biological sample derived from the subject, and comparing the amount of non-viable cells expressing telomerase with a normal amount. Increasing the number of non-viable neoplastic cells. . The methods described above evaluate neoplastic status, monitor the progress of such a condition, evaluate the effectiveness of a therapeutic agent or treatment plan, and allow the subject to progress to a more advanced disease state or enter into remission Useful for a range of applications including, but not limited to: Also provided are diagnostic agents useful for detecting telomerase proteins and / or nucleic acid molecules. [Selection figure] None |
priorityDate |
2005-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |